Positron Emission Tomography/Computed Tomography Potential Pitfalls and Artifacts

Current Problems in Diagnostic Radiology

Volumn 38, Issue 4, 2009, Pages 156-169

  Wang, Xia ^a   Koch, Spencer ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADRENAL CORTEX ADENOMA; ARTIFACT REDUCTION; BROWN ADIPOSE TISSUE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLON INJURY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG UPTAKE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INCIDENTAL FINDING; INFECTION; METABOLIC DISORDER; METAL IMPLANTATION; MUSCULOSKELETAL DISEASE; OUTCOME ASSESSMENT; OVARY DISEASE; POSITRON EMISSION TOMOGRAPHY; PYREXIA IDIOPATHICA; RADIATION ATTENUATION; REVIEW; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; THYMUS DISEASE; THYROID DISEASE; TREATMENT RESPONSE; UROGENITAL TRACT DISEASE; UTERUS DISEASE; VASCULITIS;

ARTIFACTS; FLUORODEOXYGLUCOSE F18; HUMANS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 65649131514     PISSN: 03630188     EISSN: None     Source Type: Journal    
DOI: 10.1067/j.cpradiol.2008.01.001     Document Type: Review

References (44)

1. Strauss G.J. Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients. Eur J Nucl Med 23 (1996) 1409-1415
2. Dosda R., Martí-Bonmatí L., Ronchera-Oms C.L., et al. Effect of subcutaneous butylscopolamine administration in the reduction of peristaltic artifacts in 1.5-T MR fast abdominal examinations. Eur Radiol 13 (2003) 294-298
3. Fenlon H.M., Nunes D.P., Schroy P.C., et al. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N Engl J Med 342 (1999) 1496-1503
4. 18F-FDG uptake: Incidence, localization patterns, and clinical significance. J Nucl Med 46 (2005) 758-762
5. Shreve P.D., Anzai Y., and Wahl R.L. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 19 (1999) 61-77
6. Kostakoglu L., Hardoff R., Mirtcheva R., et al. PET-CT Fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics 24 (2004) 1411-1431
7. Poole D.C., Kindig C.A., and Behnke B.J. Effects of emphysema on diaphragm microvascular oxygen pressure. Am J Respir Crit Care Med 163 (2001) 1081-1086
8. Cohade C., and Wahl R.L. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-Clinical use, interpretation methods, diagnostic improvements. Semin Nucl Med 33 (2003) 228-237
9. Kim E.E. Whole-body positron emission tomography and positron emission tomography/computed tomography in gynecologic oncology. Intl J Gynecolog Cancer 14 (2004) 12-22
10. Antoch G., Freudenberg L.S., Egelhof T., et al. Focal tracer uptake: A potential artifact in contrast-enhanced dual-modality PET/CT Scans. J Nucl Med 43 (2002) 1339-1342
11. Bujenovic S., Mannting F., Chakrabarti R., et al. Artifactual 2-deoxy-2-(18) F-fluoro-D-glucose localization surrounding metallic objects in a PET/CT scanner using CT-based attenuation correction. Mol Imaging Biol 5 (2003) 20-22
12. Wahl R.L. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. J Nuclear Med 45 suppl (2004) 82S-95S
13. Nehmeh S.A., Erdi Y.E., Kalaigian H., et al. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT. J Nucl Med 44 (2003) 1940-1944
14. Himms-Hagen J. Brown adipose tissue thermogenesis: interdisciplinary studies. FASEB J 4 (1990) 2890-2898
15. Barrington S.F., and Maisey M.N. Skeletal muscle uptake of fluorine-18-FDG: Effect of oral diazepam. J Nucl Med 37 (1996) 1127-1129
16. Alessio A.M., Kinahan P.E., Cheng P.M., et al. PET/CT scanner instrumentation, challenges, and solution. Radiol Clin North Am 42 (2004) 1017-1032
17. Gianoukakis A.G., Karam M., Cheema A., et al. Autonomous thyroid nodules visualized by positron emission tomography with 18F-fluorodeoxyglucose: A case report and review of the literature. Thyroid 13 (2003) 395-399
18. Boerner A.R., Voth E., Theissen P., et al. Glucose metabolism of the thyroid in Graves' disease measured by F-18-fluoro-deoxyglucose positron emission tomography. Thyroid 8 (1998) 765-772
19. Uematsu H., Sadato N., Ohtsubo T., et al. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors. J Nucl Med 39 (1998) 453-459
20. Kresnik E., Gallowitsch H.J., Mikosch P., et al. Fluorine-18-fluorodeoxyglucose positron tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery 133 (2003) 294-299
21. Patel P.M., Alibazoglu H., Ali A., et al. Normal thymic uptake of FDG on PET imaging. Clin Nucl Med 21 (1996) 772-775
22. Kawano T., Suzuki A., Ishida A., et al. The clinical relevance of thymic fluorodeoxyglucose uptake in pediatric patients after chemotherapy. Eur J Nucl Med Mol Imaging 31 (2004) 831-836
23. Nakahara T., Fujii H., Ide M., et al. FDG uptake in the morphologically normal thymus: Comparison of FDG positron emission tomography and CT. Br J Radiol 74 (2001) 821-824
24. Alibazoglu H., Alibazoglu B., Hollinger E., et al. Normal thymic uptake of 2-deoxy-2[F-18]fluoro-D-glucose. Clin Nucl Med 24 (1999) 597-600
25. 18F-FDG PET: Age dependency and frequency after chemotherapy. J Nucl Med 42 (2001) 591-595
26. Yun M., Kim W., Alnafisi N., et al. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 42 (2001) 1795-1799
27. Kumar R., Xiu Y., Yu J.Q., et al. 18F-FDG PET in evaluation of adrenal lesion in patients with lung cancer. J Nucl Med 45 (2004) 2058-2062
28. Boland G.W., Goldberg M.A., Lee M.J., et al. Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2deoxy-D-glucose. Radiology 194 (1995) 131-134
29. Metser U., Miller E., Lerman H., et al. 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med 47 (2006) 32-37
30. Shulkin B.L., Thompson N.W., Shapiro B., et al. Pheochromocytomas: Imaging with 2-[Fluroine-18]fluoro-2-deoxy-D-glucose PET. Radiology 212 (1999) 35-41
31. Erasmus J.J., Patz Jr. E.R., McAdams H.P., et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR 168 (1997) 1357-1360
32. Fenchel S., Grab D., Nuessle K., et al. Asymptomatic adnexal masses: Correlation of FDG PET and histopathologic findings. Radiology 223 (2002) 780-788
33. Grab D., Flock F., Stöhr I., et al. Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography. Gynecol Oncol 77 (2000) 454-459
34. Love C., Tomas M.B., Tronce G.G., et al. FDG PET of infection and inflammation. Radiographics 25 (2005) 1357-1368
35. Yen R.F., Chen Y.C., Wu Y.W., et al. Using 18-fluoro-2-deoxyglucose positron emission tomography in detecting infectious endocarditis/endoarteritis: A preliminary report. Acad Radiol 11 (2004) 316-321
36. Meller J., Altenvoerde G., Munzel U., et al. Fever of unknown origin: Prospective comparison of 18F-FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med 27 (2000) 1617-1625
37. Bleeker-Rovers C.P., de Kleijn E.M.H.A., Corstens F.H.M., et al. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 31 (2004) 29-37
38. Henry G., and Garner W.L. Inflammatory mediators in wound healing. Surg Clin North Am 83 (2003) 483-507
39. Kim E.E., Chung S.K., Haynie T.P., et al. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. Radiographics 12 (1992) 269-279
40. Greven K.M., Williams III D.W., Keyes Jr. J.W., et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 74 (1994) 1355-1359
41. Nakayama Y., Makino S., Fukuda Y., et al. Activation of lavage lymphocytes in lung injuries caused by radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 32 (1996) 459-467
42. Kobori O., Kirihara Y., Kosaka N., et al. Positron emission tomography of esophageal carcinoma using (11)C-choline and (18)F-fluorodeoxyglucose: A novel method of preoperative lymph node staging. Cancer 86 (1999) 1638-1648
43. Flanagan F.L., Dehdashti F., Ogunbiyi O.A., et al. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 227 (1998) 319-323
44. Shon I.H., O'Doherty M.J., and Maisey M.N. Positron emission tomography in lung cancer. Semin Nucl Med 32 (2002) 240-271